LEADER 02990nam  22005535  450 
001 9910349452003321
005 20200705224456.0
010   $a3-030-16814-X
024 7 $a10.1007/978-3-030-16814-8
035   $a(CKB)4100000008780931
035   $a(MiAaPQ)EBC5841069
035   $a(DE-He213)978-3-030-16814-8
035   $a(PPN)238491463
035   $a(EXLCZ)994100000008780931
100   $a20190726d2019      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aLichen Secondary Metabolites $eBioactive Properties and Pharmaceutical Potential /$fedited by Branislav Rankovi?
205   $a2nd ed. 2019.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019.
215   $a1 online resource (206 pages)
311   $a3-030-16813-1 
320   $aIncludes bibliographical references.
327   $aLichens as a potential source of bioactive secondary metabolites -- Lichens used in traditional medicine -- Lichen secondary metabolites as potential antibiotic agents -- Studies on antioxidant properties of lichen secondary metabolites -- Investigations of lichen secondary metabolites with potential anticancer activity -- Antigenotoxic effect of some lichen metabolites -- Lichen secondary metabolites as possible antiviral agents -- Future directions in the study of pharmaceutical potential of lichens.
330   $aThis revised and extended edition provides in-depth insights into the benefits and untapped potential of lichen-derived bioactive compounds. The whole spectrum of these compounds? biological and medical functions, from antibiotic to antiviral and anti-carcinogenic properties, is presented. In addition, a new chapter discusses the anti-neurodegenerative and anti-diabetic activities of lichenic secondary metabolites. Given its scope, the book offers a valuable asset for students and researchers in this field.
606   $aMicrobiology
606   $aPharmacology
606   $aMycology
606   $aEukaryotic Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/L23020
606   $aApplied Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/C12010
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aMycology$3https://scigraph.springernature.com/ontologies/product-market-codes/L27000
615  0$aMicrobiology.
615  0$aPharmacology.
615  0$aMycology.
615 14$aEukaryotic Microbiology.
615 24$aApplied Microbiology.
615 24$aPharmacology/Toxicology.
615 24$aMycology.
676   $a612.39
676   $a612.39
702   $aRankovi?$b Branislav$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910349452003321
996   $aLichen Secondary Metabolites$91994008
997   $aUNINA